Sina Halvaei
Impact in
-
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Gut microbiota and health
- Epigenetics and DNA Methylation
Papers in
-
- Extracellular vesicles in disease 5
- Glycosylation and Glycoproteins Research 1
-
- Nanopore and Nanochannel Transport Studies 2
- Co-authors
- Rezvan Esmaeili (3 shared papers)Zahra Eslami‐S (2 shared papers)Keivan Majidzadeh‐A (2 shared papers)Ghamartaj Hossein (1 shared paper)Nima Naderi (1 shared paper)Akram Alizadeh (1 shared paper)Reza Sahebi (1 shared paper)Maryam Aghaei (1 shared paper)
- Journals
- Frontiers in Oncology (1 paper)Cancer Medicine (1 paper)Journal of Physics Photonics (1 paper)Molecular Therapy — Nucleic Acids (1 paper)Nanoscale Advances (1 paper)
- Partner nations
- IranCanadaUnited States
In The Last Decade
Sina Halvaei
9 papers receiving 336 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 100
- Molecular Biology 225
- Oncology 51
- Immunology 40
- Aging 2
Countries citing papers authored by Sina Halvaei
This map shows the geographic impact of Sina Halvaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sina Halvaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sina Halvaei more than expected).
Fields of papers citing papers by Sina Halvaei
This network shows the impact of papers produced by Sina Halvaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sina Halvaei. The network helps show where Sina Halvaei may publish in the future.
Co-authors
The 18 scholars most cited alongside Sina Halvaei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 152 | |
| 2 | 2020 | 117 | |
| 3 | 2019 | 39 | |
| 4 | 2017 | 15 | |
| 5 | 2023 | 9 | |
| 6 | 2024 | 3 | |
| 7 | 2025 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2025 | 1 |
About Sina Halvaei
Sina Halvaei is a scholar working on Molecular Biology, Biomedical Engineering, Genetics, Cancer Research and Genetics, having authored 9 papers that have together received 338 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (2 papers), Nanopore and Nanochannel Transport Studies (2 papers), Glycosylation and Glycoproteins Research (1 paper), High Altitude and Hypoxia (1 paper), Galectins and Cancer Biology (1 paper), Radiation Therapy and Dosimetry (1 paper) and Digestive system and related health (1 paper). The work is most often cited by research in Cancer Research (100 citations), Molecular Biology (225 citations), Oncology (51 citations), Immunology (40 citations) and Aging (2 citations). Sina Halvaei has collaborated with scholars based in Iran, Canada and United States. Frequent co-authors include Rezvan Esmaeili, Zahra Eslami‐S, Keivan Majidzadeh‐A, Ghamartaj Hossein, Nima Naderi, Akram Alizadeh, Reza Sahebi, Maryam Aghaei, Karla C. Williams and Andrew C. Johnson. Their work appears in journals such as Frontiers in Oncology, Cancer Medicine, Journal of Physics Photonics, Molecular Therapy — Nucleic Acids and Nanoscale Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.